First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...

Chinese pharma Hansoh Pharma (HKEX: 3692) has secured approval from China’s National Medical Products Administration for an ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

Tovia Anyanwu, a kidney failure survivor, shares her shocking diagnosis after childbirth, her family's struggle, and how ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

EpiBiologics launched in 2023 with a $50 million series A, having been founded to take forward the work of renowned antibody ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to organ ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...

Explore the stages and prevalence of chronic kidney disease, highlighting risk factors and the importance of early detection ...

The Alpestria-1 study enrolled (in France, USA and Spain) 26 patients with Alport syndrome at high risk of a rapid loss of kidney function despite stable multiple SoC drugs, including ...

Here's how to tell if your heart is trending towards accelerated aging—and what to do if it is, according to an expert cardiologist.